BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18813120)

  • 21. p63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions.
    Shiran MS; Tan GC; Sabariah AR; Rampal L; Phang KS
    Med J Malaysia; 2007 Mar; 62(1):36-9. PubMed ID: 17682568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma.
    Chuang AY; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1225-30. PubMed ID: 17667547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
    Parwani AV; Herawi M; Epstein JI
    Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies.
    Hosler GA; Epstein JI
    Hum Pathol; 2005 May; 36(5):480-5. PubMed ID: 15948114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
    Yu T; Zhu SX; Zheng S; Chen SP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides.
    Duffield AS; Epstein JI
    Am J Surg Pathol; 2009 Jan; 33(1):120-5. PubMed ID: 18971774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy.
    Aydin H; Zhou M; Herawi M; Epstein JI
    Hum Pathol; 2005 Nov; 36(11):1172-7. PubMed ID: 16260270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
    Osunkoya AO; Netto GJ; Epstein JI
    Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 expression profile in normal and malignant prostate epithelial cells.
    Davis LD; Zhang W; Merseburger A; Young D; Xu L; Rhim JS; Moul JW; Srivastava S; Sesterhenn IA
    Anticancer Res; 2002; 22(6C):3819-25. PubMed ID: 12553000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A subset of prostate basal cells lacks the expression of corresponding phenotypic markers.
    Man YG; Zhao C; Chen X
    Pathol Res Pract; 2006; 202(9):651-62. PubMed ID: 16842934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
    Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
    BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.
    Kunju LP; Rubin MA; Chinnaiyan AM; Shah RB
    Am J Clin Pathol; 2003 Nov; 120(5):737-45. PubMed ID: 14608901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
    Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
    Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 immunostaining in destained bronchoscopic cytological specimens.
    Shtilbans V; Szporn AH; Wu M; Burstein DE
    Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
    Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
    J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of p63 for distinction of glandular versus squamous lesions in cervicovaginal specimens.
    Garcia MT; Acar BC; Jorda M; Gomez-Fernandez C; Ganjei-Azar P
    Cancer; 2007 Feb; 111(1):54-7. PubMed ID: 17173320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
    Herawi M; Parwani AV; Irie J; Epstein JI
    Am J Surg Pathol; 2005 Jul; 29(7):874-80. PubMed ID: 15958851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
    Adley BP; Yang XJ
    Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.